FDA Reclassification Expected 2026

Peptide Therapy — Coming Soon

14 peptides are expected to return to legal compounding status in 2026. Explore each one and join the waitlist for physician-guided therapy through Zelvimed.

All Peptides
B

BPC-157

Body Protection Compound-157

The Body's Repair Peptide

T

TB-500

Thymosin Beta-4 Fragment

Advanced Muscle & Joint Recovery

A

AOD-9604

Anti-Obesity Drug 9604

Targeted Fat Metabolism Support

G

GHK-Cu

Copper Peptide GHK-Cu

The Regeneration & Anti-Aging Peptide

T

Thymosin Alpha-1

Thymosin Alpha-1

Immune System Optimization

C

CJC-1295

CJC-1295 (with or without DAC)

Growth Hormone Optimization

I

Ipamorelin

Ipamorelin

Precise Growth Hormone Release

S

Selank

Selank

Cognitive Enhancement & Anxiety Relief

S

Semax

Semax

Neuroprotection & Mental Performance

K

KPV

KPV (Lysine-Proline-Valine)

Anti-Inflammatory & Gut Health

M

MOTS-c

Mitochondrial Open Reading Frame of the 12S rRNA-c

The Exercise Mimetic Peptide

E

Epitalon

Epitalon (Epithalamin)

Telomere & Longevity Science

Already Looking for GLP-1 Weight Loss?

Our physician-guided GLP-1 program is live now. Semaglutide and tirzepatide delivered to your door, starting at $149/mo.

Take the Eligibility Quiz →